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Abstract
Background: US Asian women with early-stage breast cancer are more likely to receive a
modified radical mastectomy (MRM) than White women, contrary to clinical recommendations
regarding breast conserving treatment (BCT).
Methods: We surveyed physicians regarding treatment decision-making for early-stage breast
cancer, particularly as it applies to Asian patients. Physicians were identified through the
population-based Greater Bay Area Cancer Registry. Eighty (of 147) physicians completed a
questionnaire on sociodemographics, professional training, clinical practices, and perspectives on
the treatment decision-making processes.
Results: The most important factors identified by physicians in the BCT/MRM decision were
clinical in nature, including presence of multifocal disease (86% identified this as being an important
factor for selecting MRM), tumor size (71% for MRM, 78% for BCT), cosmetic result (74% for BCT),
and breast size (50% for MRM, 55% for BCT). The most important reasons cited for the Asian
treatment patterns were patient attitudes toward not needing to preserve the breast (53%),
smaller breast sizes (25%), and fear and cultural beliefs (12%).
Conclusion: These survey results suggest that physicians perceive major roles of both clinical and
cultural factors in the BCT/MRM decision, but cultural factors may be more relevant in explaining
surgical treatment patterns among Asians.
Background
For most patients with early-stage breast cancer, breast
conserving treatment (BCT) provides a less invasive alter-
native to modified radical mastectomy (MRM) with
equivalent survival [1] and possibly also better quality of
life [2,3]. The use of BCT, however, occurs disproportion-
ately in the US, with substantial ethnic, geographic and
socioeconomic variation [4-8]. Asian women have MRM
at significantly higher rates [5,7,9-11]; for example, in
California, among stage 0–II breast cancer patients diag-
nosed in 1988–1995, 67.5% of Asians had MRM com-
pared to 57.3% of Whites [5]. This proportion is even
higher among certain Asian populations; more current
data from the national Surveillance, Epidemiology, and
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End Results (SEER) program show that 54% of Vietnam-
ese, 53% of Filipinas, and 48% of Chinese diagnosed with
early-stage breast cancer between 1988–2005 had MRM,
compared to 39–42% of non-Hispanic Whites, Blacks,
and Hispanics [9,12]. BCT, which typically requires an
average of five weeks of adjuvant radiation, may be less
feasible for those who live far from treatment facilities
and/or have travel limitations [13,17]. There are also clin-
ical contraindications to BCT, such as small breast size,
and a high tumor to breast size ratio [1], although it is
unclear whether these clinical contraindications would
explain the substantially lower rates of BCT among certain
Asian populations. Other factors such as poor patient-pro-
vider communication, language barriers, and cultural fac-
tors may also affect the patterns seen in cancer
surveillance data, yet patient sociodemographic or tumor
characteristics have not been shown to explain the differ-
ences in treatment patterns across ethnic groups
[7,11,18]. Qualitative research suggests that Asian cultural
characteristics and beliefs about physical appearance, fate,
and the safety and effectiveness of BCT, as well as difficul-
ties with adjuvant treatment and cross-cultural misunder-
standings in the doctor-patient encounter, may explain
the higher frequency of MRM over BCT [10,19].
Physician perspectives can provide valuable insight into
the decision-making process, and consequently, may help
to identify reasons for racial/ethnic variations in treat-
ment patterns. Factors such as provider gender [20],
period of provider training [21], extent of communication
between physician and patient [20], and hospital of diag-
nosis or distance to hospital or treatment facility [22]
appeared to be associated with differences in choice of
MRM between Black and White patients. The literature
also documents limited concordance between patients'
preferred role, with regards to autonomy and participa-
tion, and physician perception of this role in the decision-
making process for breast cancer treatment [23], and for
cancer treatment in general [24].
Because of the documented importance of physicians' per-
spectives in decisions regarding cancer treatment, and for
understanding the persistently higher rates of MRM
among Asian populations, we surveyed physicians from
the Greater San Francisco Bay Area on their perspectives
regarding the factors important in deciding between BCT
and MRM. This survey is part of a larger pilot study of deci-
sion-making processes as they relate to ethnic disparities
in receipt of optimal breast cancer treatment. This pilot
study also included focus groups with breast cancer
patients, and qualitative one-on-one interviews with
patients and a "co-decision maker," and was designed to
be a mixed methods study that incorporated all of the
information gathered from the patient, co-decision
maker, and provider interviews into a quantitative instru-
ment, which was subsequently cognitive and pilot tested.
Methods
Selection of Physicians
Physicians were identified through the nine-county, pop-
ulation-based Greater Bay Area Cancer Registry (GBACR),
a participant in SEER and in the California Cancer Registry
(CCR). The GABCR covers a region of approximately 3
million residents and a racially/ethnically, socioeconomi-
cally, and geographically diverse population [25]. The
names of the attending and follow-up physician of each
breast cancer case, as well as their mailing address, are
available from GBACR data. Other data, including physi-
cian sociodemographics and clinical specialty, are not
available. Based on GBACR data for approximately 700
Chinese, 500 Filipina, and 120 Vietnamese incident
breast cancer patients diagnosed during the years 2002–
2004, we generated an eligibility sample of 50 physicians
who had diagnosed and/or treated proportionally the
most patients in each of these three racial/ethnic groups,
for a total eligibility sample of 150 physicians.
Survey Instrument
The pre-tested, self-administered, mailed questionnaire
consisted of 21 questions on physician socio-demograph-
ics, professional training and specialty, reported practices
and guidelines, and perspectives on the treatment deci-
sion-making processes and factors considered important
in treatment decisions. We also inquired about the overall
racial/ethnic composition of each physician's patients, the
extent to which clinical practice guidelines (or equivalent)
were employed, and the estimated proportion of early-
stage breast cancer patients treated with MRM. Questions
about treatment decision-making processes developed by
Bruera et al. [24] and Degner et al. [26] were adapted for
use in this study. We also elicited physicians' perspectives
on reasons why they thought Asian patients diagnosed
with early-stage breast cancer are more likely to have MRM
over BCT compared to the general population.
Data Collection
Eligible physicians were mailed, in 2005, a packet that
included a cover letter describing the study and inviting
them to participate by completing the enclosed question-
naire; completed questionnaires were received in 2005–
2006. As an incentive to return the survey, a money order
for $15 was included. Telephone calls were made to
encourage participation. Of the 150 physicians, three were
deemed ineligible, and 80 surveys were completed, yield-
ing a response rate of 54%. Since the physicians were
identified through the cancer registry, information on
sociodemographic or other characteristics such as spe-
cialty type were not available for assessing whether
respondents were different from non-respondents.
Statistical Analysis
The primary outcomes of interest were information about
physician practices and perspectives regarding treatmentBMC Public Health 2009, 9:246 http://www.biomedcentral.com/1471-2458/9/246
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decision-making. We conducted descriptive analyses of
the physicians' reported practices and perspectives (Tables
1 and 2). We also conducted exploratory multivariable
logistic regression of the associations between selected
physicians' practices and perspectives and physician
demographic characteristics. Analyses were performed
using the R statistical program [27].
Results
Table 3 shows the frequencies of physician demographic
characteristics. A relatively large proportion of our
respondents were male (66%), ranged in age from 40 to
59 years (65%), and self-identified as non-Hispanic
Whites (63%). Most of the physicians were US-born
(73%), over half spoke English only (59%), but many
have had to discuss treatment in a foreign language (64%,
often through an interpreter). 18% percent of physicians
received training in oncology during their residency, and
35% during their fellowship.
Physician practices and policies are reported in Table 3.
Largely attributable to our selection criteria, 77% of phy-
sicians reported that "several" (20–90%) to "most"
(greater than 90%) of the breast cancer patients they
treated over the past two years were Asian. Only 4%
treated more than 90% of their stage I and II breast cancer
patients with MRM. In general, the physician-reported
proportions of patients receiving MRM appear to be
slightly lower than those based on population-based can-
cer registry data. These differences may be due to several
factors, including some recall bias on the part of the phy-
sicians, and the differences in their patient populations by
race/ethnicity and other sociodemographic factors.
Physician perspectives on important factors in the treat-
ment decision are shown in Table 2. Frequently reported
factors include clinical factors (tumor size, multifocal dis-
ease), breast size, and patient's attitude toward preserving
the breast. For patients treated with BCT, 87.5% of physi-
cians considered patient's attitude toward preserving the
breast to be the most important factor, and 74% of physi-
cians also considered cosmetic result to be important.
53% of physicians believed Asian women are more likely
to have MRM because of patient attitudes about breast
preservation, and 25% believed that breast size also plays
a strong role. Physicians also listed fear and/or cultural
beliefs as "other factors" influencing MRM decisions
among Asian women.
Table 1: Distribution of patient characteristics, practices, and guidelines, as reported by physicians (N = 80), Greater San Francisco 
Bay Area, 2005–2006
Characteristics, practices, guidelines N None A Few (<20%) Several Most (>90%)
% * % * % * % *
Race/Ethnicity of patients treated over last 2 years
Non-Hispanic White 75 1.3 9.3 60.0 29.3
Hispanic 76 6.6 31.6 60.5 1.3
African American/Black 77 9.1 52.0 39.0 0.0
Asian/Pacific Islander 78 1.3 21.8 65.4 11.5
Patient decision-making preferences for treatment
Patient alone 76 18.4 51.3 17.1 13.2
Patient with physician input 78 0.0 10.3 39.7 50.0
Shared decision 78 0.0 15.4 38.5 46.2
Physician with patient input 76 13.2 60.5 21.0 5.3
Physician alone 77 45.4 42.9 11.7 0.0
Hospital has facility-specific clinical practice guidelines (CPG) for patients Yes No
80 27.5 72.5
Number of patients for whom physicians employ these CPG 
(among practices with CPGs, N = 23)
23 0.0 8.7 4.4 87.0
Number of stage I and II breast cancer patients treated with MRM 74 1.4 68.9 25.7 4.0
*Missing responses not included in percent calculations.BMC Public Health 2009, 9:246 http://www.biomedcentral.com/1471-2458/9/246
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We assessed associations between physicians' practices
and perspectives and physician demographic characteris-
tics using logistic regression (data not shown). Although
based on a small sample, we found that Asians were less
likely than physicians of other ethnicities to report cos-
metic result as an important factor for patients choosing
BCT (OR = 0.13, 95% CI = 0.04–0.40); male physicians
were more likely than females to think cosmetic result was
important in BCT decisions (OR = 5.22, 95% CI = 1.76–
15.49), and less likely to perceive that patient travel con-
cerns were important (OR = 0.21, 95% CI = 0.08–0.58).
When attempting to explain Asian treatment patterns,
Asian physicians were more likely to perceive that patient
age (OR = 5.00, 95% CI = 1.10–22.63) and travel concerns
(OR = 7.65, 95% CI = 1.38–42.56) were important fac-
tors. The full logistic regression results are available upon
request.
Discussion
Breast cancer is the most commonly diagnosed cancer
among Asian women [28-30], with the majority of cancers
diagnosed at an early-stage. Because BCT is a recom-
mended alternative to MRM, the fact that the vast majority
of Asian women still have MRM is a concern, particularly
if this treatment pattern reflects disparities in the delivery
of guideline-recommended treatment. We found that
physicians believed that patient attitudes toward [not]
preserving the breast was the predominant reason for the
higher rate of MRM among Asian women compared to
other racial/ethnic groups. This finding supports sugges-
Table 2: Physician perspective on factors determining treatment decisions (N = 80), Greater San Francisco Bay Area, 2005–2006
Physician perspective % indicating "yes" *
Most important factors for stage I and II patients treated with MRM over last 2 years
Presence of multifocal or multicentric disease 86.2
Tumor size 71.2
Patient's attitude toward preserving the breast 66.2
Breast size 50.0
Age 28.8
Location of tumor 25.0
Patient's ability/willingness to travel to receive adjuvant radiation therapy 22.5
Family history 18.8
Cosmetic result 17.5
Adverse effects/outcome 6.2
Most important factors for stage I and II patients treated with BCT over last 2 years
Patient's attitude toward preserving the breast 87.5
Tumor size 77.5
Cosmetic result 73.8
Breast size 55.0
Patient's ability/willingness to travel to receive adjuvant radiation therapy 38.8
Presence of multifocal or multicentric disease 32.5
Age 30.0
Location of tumor 22.5
Adverse effects/outcome 7.5
Family history 6.2
Reasons why Asian subgroups are more likely to get MRM over BCT
Patient's attitude toward preserving the breast 52.5
Breast size 25.0
Age 11.2
Patient's ability/willingness to travel to receive adjuvant radiation therapy 10.0
Tumor size 8.8
Adverse effects/outcome 8.8
Cosmetic result 7.5
Presence of multifocal or multicentric disease 6.2
Location of tumor 5.0
Family history 2.5
Don't know 17.5
Other 18.8
Cultural factors 6.2
Fear 6.2
*Non-response was counted as "No" for that factor.BMC Public Health 2009, 9:246 http://www.biomedcentral.com/1471-2458/9/246
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tions from qualitative studies that a primary reason for the
observed surgical treatment pattern among Asians is
reduced emphasis on physical appearance when making
treatment decisions, reflective of cultural norms that place
less significance on the breasts in particular [10,19]. This
physician survey was conducted as part of a larger pilot
study to evaluate such cultural factors and the role that
they play in the complex decision-making process among
Asian women diagnosed with early-stage breast cancer.
The second most commonly cited reason for the Asian
surgical treatment pattern was breast size, given that BCT
is often not clinically feasible considering the relatively
small breasts among Asian women [1]. Our study did not
show tumor size to be considered an important reason,
which is consistent with prior studies that either have not
shown a difference in tumor size distribution between
Asian and non-Asian women [7,18] or modest differences
that were insufficient to explain the ethnic treatment dif-
ferences [8,9]. These findings together suggest that MRM
is more often performed on Asian women possibly
because of contraindications in large tumor-to-breast
ratios, which is primarily driven by small breast size,
rather than large tumor sizes; however, tumor-to-breast
ratio alone seems unlikely to explain all of the ethnic
treatment differences. Because our findings consist of phy-
sician beliefs, further studies based on objective measures
are needed to verify this finding.
The role of patient-provider cultural concordance may be
relevant when examining Asian physicians' perspectives
on decision-making process and treatment factors. Do
Asian physicians draw from their own cultural experiences
when interacting with Asian patients and when recalling
patient treatment decisions? For example, difficulty in
travel to receive adjuvant therapy (required as part of the
full course of BCT) has been often considered as a reason
for receipt of MRM over BCT [13-17], and proposed as a
reason for the Asian treatment pattern [7]. Although few
doctors in our study believed that this would explain why
Asian patients are less likely to choose BCT, six of the eight
doctors in our study that did perceive travel concerns to be
a reason for the Asian treatment difference were of Asian
race/ethnicity. Asian physicians were also much more
likely to report that patient age may explain why Asian
patients are more likely to choose MRM. It is difficult to
determine whether this suggests that they believe that
Asian breast cancer patients have a different age distribu-
tion from non-Asian patients, or whether they believe that
Asian patients strongly link age to other treatment-rele-
vant factors such as cosmetic result, attitude toward pre-
serving the breast, and ability to travel. Asian physicians
were also more likely to report that patients prefer that the
physician makes the decision alone, suggesting cultural
concordance as well as an implicit acknowledgement of
the cultural belief in deference over medical professionals.
Cultural concordance may play positive roles in patient
care, as it has been associated with greater satisfaction
with care [31], use of needed health services and less delay
in seeking care, although these associations have been
shown to be stronger for Whites and Blacks and less
marked for Hispanics and Asians [32]. However, race con-
cordance may result in poorer care; for example, it has
been observed that physician sympathy for patient beliefs
regarding cultural modesty and lack of emphasis on the
importance of preventive care was associated with fewer
recommendations for breast and cervical cancer screening
[33].
The design aspect of this survey was limited in its ability
to explore other factors in the decision-making process
and possible explanations for Asian treatment patterns.
For example, the study did not match providers to
patients and did not attempt to examine concordance
between patient and physician responses. Additionally,
Table 3: Distribution of physician demographic characteristics 
(N = 80), Greater San Francisco Bay Area, 2005–2006
Characteristic n % *
Gender
Male 53 66.2
Female 27 33.8
Age (years)
Under 40 11 13.8
40–49 22 27.5
50–59 30 37.5
60 and over 17 21.2
Race/Ethnicity
Asian 26 32.5
Non-Asian 54 67.5
Country of Origin
USA 58 72.5
Not USA 22 27.5
Age Immigrated to US
US Born 58 72.5
<18 yrs old 10 12.5
18+ yrs old 12 15.0
Foreign Language Fluency
English only 47 58.8
Speaks more than English 33 41.2
Discussed treatment in foreign language
Yes 51 63.8
No 23 28.8
Residency specialty
Medicine/Family 17 21.2
General Surgery 48 60.0
Radiation Oncology 14 17.5
Fellowship specialty
Breast or Oncology 28 35.0
Other specialty 13 16.2
None 39 48.8
*Missing responses not included in percent calculations.BMC Public Health 2009, 9:246 http://www.biomedcentral.com/1471-2458/9/246
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because physicians were selected based on the proportion
of Chinese, Vietnamese, or Filipina patients treated, and
given the heterogeneity among Asian subgroups, these
results may not be applicable to patients of other Asian
ethnicities.
Although this physician survey was conducted as part of a
larger pilot study and was designed to be exploratory in
nature, we were able to show that, from physicians' per-
spectives, while the main factors in deciding between BCT
and MRM are clinical in nature, major reasons for the
observed differences in surgical treatment patterns among
Asian women are also believed to be psychological and
cultural in nature. A main reason cited for electing BCT in
general, and for the Asian treatment pattern is attitude
toward preserving the breast. Although many of these cul-
tural factors require additional research for a more com-
plete understanding of their role and significance,
physician awareness of these factors will allow them to
incorporate this knowledge into their interactions with
Asian breast cancer patients. In cases where there are no
clear clinical contraindications to BCT, physicians should
directly address the patient's attitude toward preserving
the breast as well as other cultural factors. When a patient
expresses that preserving the breast is not important, are
they actually masking a fear of adverse outcomes or adju-
vant therapy? Providers should be sure that patients are
fully informed of their treatment options and of the con-
sequences of each option. Finally, if travel is a barrier, as
suggested through other studies of the general population
[13-17], it should be possible to remove this barrier,
either by providing private travel services or through coor-
dination with existing public health or community pro-
grams. Through deeper understanding of the treatment
decision-making process among Asian women is needed,
early efforts such as these could contribute to reducing the
racial/ethnic disparities in receipt of optimal breast cancer
treatment.
Conclusion
In conclusion, this study of providers who have treated
early-stage Asian breast cancer patients in the Greater San
Francisco Bay Area showed that physicians perceive major
roles of both clinical and cultural factors in the breast con-
serving therapy versus modified radical mastectomy deci-
sion, but psychological and cultural factors may be more
relevant in explaining the previously documented higher
MRM patterns among Asians.
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